Skip to content

Dr. ISABELLE THEETAERT

Active
Private limited companyfounded 2020active for 6 yearsKapelaanstraat 15, 8310 Brugge, BelgiumKBO/BCE: BE 0745.972.164
Summary

Dr. ISABELLE THEETAERT has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €32,684 and a net result of €27,684. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 49% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 14-04-2020 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.302.281.142 8310 Brugge, since 14-04-2020
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
  • Theetaert IsabelleDirector

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€42,812
▲ 134%
Turnover
≈ €130,000
estimated
Profit
€27,684
▲ 168%
Equity
€32,684
▲ 33.5%
Total assets
€52,833
▲ 5.9%
Filed on 02-07-2026, 29 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.38, cash €36,122Size: total assets €52,833Equity €32,684 (61.9% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 67% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 87+13
equity 61.9% of total assets
Liquidity 84+9
short-term debt 35.8% · cash 68.4%
Profitability 100+5
return on assets 52.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.38 (1.91 in 2024), above the usual 1.5. Short-term debt is 35.8% and cash 68.4% of total assets. 38.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 50% of them on solvency, 66% on liquidity, 80% on profitability and 74% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.38, cash €36,122
NBB · annual accounts
lowers risk · Size: total assets €52,833
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €32,684 (61.9% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
202122232425
2020 to 2025 · latest year €32,684
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
29 days early
2024
13 days early
2023
34 days early
2022
27 days early
2021
24 days late
2020
32 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 8 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 6 profitable years in a rowprofit 2025: €27,684 6 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Registered office moved from Leuven to Sint-Kruis
  2. · Gazette deed Incorporation
All 12 events

Comparable companies

These companies have the same main activity as Dr. ISABELLE THEETAERT: general medical practice (NACE 86210). They are comparable in size and age: total assets between €49,300 and €62,100, founded between 2019 and 2021.

CompanyTotal assetsGross margin
Dr. ISABELLE THEETAERT Brugge€52,833€42,812
Dr. Elien Gheysens Brugge€56,096€39,982
DR. GUDRUN DECONINCK Brugge€51,475€39,910
Dr. Jolien Decroo - huisarts Kortrijk€52,833€49,160
Dokter Maaike Verbeke, Huisarts bv Gent€49,293€48,404
Dokter Annelies Deschepper, Huisarts Asse€49,327€37,850
Curans Leuven€62,060€44,135
Full comparison

Key facts about Dr. ISABELLE THEETAERT

What is the company number of Dr. ISABELLE THEETAERT?
The company number of Dr. ISABELLE THEETAERT is 0745.972.164. The VAT number is the same number with BE in front: BE 0745.972.164.
Where is Dr. ISABELLE THEETAERT based?
The registered office is at Kapelaanstraat 15, 8310 Brugge.Company details
What does Dr. ISABELLE THEETAERT do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. ISABELLE THEETAERT?
The legal form of Dr. ISABELLE THEETAERT is Private limited company (BV).
When was Dr. ISABELLE THEETAERT founded?
Dr. ISABELLE THEETAERT was founded on 14-04-2020.
Is Dr. ISABELLE THEETAERT still active?
Yes, Dr. ISABELLE THEETAERT is an active enterprise in the KBO register.
What is the turnover of Dr. ISABELLE THEETAERT?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €42,812 and 47 comparable companies (NACE 86). It probably lies between €95,000 and €190,000.Financials
Is Dr. ISABELLE THEETAERT profitable?
In financial year 2025, Dr. ISABELLE THEETAERT made a profit of €27,684.
Where can I find the annual accounts of Dr. ISABELLE THEETAERT?
Dr. ISABELLE THEETAERT filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. ISABELLE THEETAERT due?
Dr. ISABELLE THEETAERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.